Kisspeptin vs hCG: Studying the Reproductive Axis From the Top or the Bottom
In brief. Kisspeptin and hCG both lead to sex-steroid production, but they enter the hormone chain at opposite ends. Kisspeptin acts in the hypothalamus, upstream of GnRH. hCG acts directly on the gonads through the LH receptor, bypassing the brain and pituitary. Which one you use depends on which part of the axis you want to test.
The hypothalamic-pituitary-gonadal (HPG) axis is a relay. The hypothalamus releases GnRH, GnRH tells the pituitary to release LH and FSH, and those hormones act on the testes or ovaries. A research compound can enter that relay at different points, and where it enters decides what its results can tell you.
Kisspeptin: the signal at the top
Kisspeptins are peptides encoded by the KISS1 gene. The longest form has 54 residues. Kisspeptin-10 is its C-terminal ten-residue fragment (YNWNSFGLRF-NH2), which keeps full activity at the receptor. That receptor, KISS1R (also called GPR54), sits on GnRH neurons in the hypothalamus.
Kisspeptin’s importance became clear in 2003, when two research groups reported that loss of KISS1R function prevents normal puberty. Since then it has been understood as a gatekeeper of GnRH release. When kisspeptin activates its receptor, GnRH is released, and the rest of the axis follows.
hCG: the signal at the bottom
Human chorionic gonadotropin is a large glycoprotein hormone, around 36 to 38 kDa, made of two subunits. Its alpha subunit is shared with LH, FSH and TSH. Its beta subunit closely resembles LH but carries an extra C-terminal stretch with added sugar chains, which slows clearance.
hCG binds the LH/choriogonadotropin receptor directly on Leydig cells in the testes and theca cells in the ovaries. It does not need the hypothalamus or the pituitary. It simply substitutes for LH at the end of the chain.
Why entry point matters
| Kisspeptin-10 | hCG | |
|---|---|---|
| Molecule | 10-residue peptide | Two-subunit glycoprotein |
| Receptor | KISS1R (GPR54) | LH/CG receptor |
| Site of action | Hypothalamus | Gonads |
| Needs a working pituitary? | Yes | No |
| Raises LH and FSH? | Yes, through GnRH | No, it acts in place of LH |
| Effect on the brain’s own feedback | Engages it | Bypasses it |
This makes the two compounds complementary rather than interchangeable. Kisspeptin tests whether the whole relay is intact: a normal LH response tells you the hypothalamus, pituitary and their connections work. hCG tests only the last step: whether the gonads can respond to an LH-type signal.
Using them together in study design
- In animal models of suppressed reproductive function, comparing responses to both compounds can show whether the problem lies in the brain, the pituitary or the gonad.
- Kisspeptin responses are short-lived and pulse-like, so sampling needs to be frequent. hCG produces a slower, more sustained response.
- Because kisspeptin works through GnRH, a GnRH antagonist will block its effect but not hCG’s. That is a useful control.
Keeping it in scope
This article describes reproductive endocrinology and preclinical research. It does not describe effects in people, and Resolve materials are for laboratory research only. Resolve supplies kisspeptin-10; lot documentation is on the COA / Lab Reports page, and our Research Use Only policy explains permitted use.